高龄女性生育力评估及辅助生育

doi:10.6040/j.issn.1671-7554.0.2016.1331

摘要/Abstract

摘要： 女性生育力随年龄下降主要体现在卵巢功能降低和子宫内膜容受性下降,高龄女性应及时接受生育力评估。目前对高龄助孕年龄的界定尚存争议,多数生殖中心将其定为43~45岁。在高龄女性行辅助生殖技术时,重点是增加获卵数和改善卵子质量,无可用卵子的高龄女性可考虑赠卵,同时不要忽视随年龄增加的母婴风险。

关键词: 妊娠结局, 高龄, 辅助生殖技术, 生育力

Abstract: Female fertility declines with age, characterized by poor ovarian function and endometrial receptivity. Therefore, elder women who expect pregnancy should have their fertility evaluated first. At present, there is controversy as to the upper age limit for assisted reproductive technology, which is defined by most infertility centers as 43-45yrs. The focus of ART is to improve the quantity and quality of retrieved oocytes. For women without available oocytes, donation can be an alternative. In addition, age-related maternal and child risks should be taken into consideration.

Key words: Fertility, Assisted reproductive technology, Advanced parental age, Pregnancy outcome

中图分类号:

R711.6

邓晓惠,徐亚瑄. 高龄女性生育力评估及辅助生育[J]. 山东大学学报（医学版）, 2017, 55(1): 5-10.

DENG Xiaohui, XU Yaxuan. Fertility evaluation and assisted reproduction in elder women[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 5-10.

参考文献

[1] American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and Practice Committee. Female age-related fertility decline. Committee Opinion No. 589[J]. Fertil Steril, 2014, 101(3): 633-663.
[2] 王若琳, 钱卫平, 周亮, 等. 高龄对卵母细胞质量的影响[J]. 生殖与避孕, 2016, 36(9): 752-757.
[3] Demko ZP, Simon AL, McCoy RC, et al. Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism-based preimplantation genetic screening[J]. Fertil Steril, 2016, 105(5): 1307-1313.
[4] Roberts SA, Hiest WM, Brison DR, et al. Embryo and uterine influences on IVF outcomes: an analysis of a UK multi-centre cohort[J]. Hum Reprod, 2010, 25(11): 2792-2802.
[5] Seckin B, Turkcapar F, Ozaksit G. Elevated day 3 FSH/LH ratio: a marker to predict IVF outcome in young and older women[J]. J Assist Reprod Genet, 2012, 29(3): 231-236.
[6] Cui L, Qin Y, Gao X, et al. Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause[J]. Fertil Steril, 2016, 105(2): 481-485.
[7] Barbakadze L, Kristesashvili J, Khonelidze N, et al. The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women[J]. Int J Fertil Steril, 2015, 8(4): 393-398.
[8] Gohari MR, Ramezani Tehrani F, Chenouri S, et al. Individualized predictions of time to menopause using multiple measurements of antimüllerian hormone[J]. Menopause, 2016, 23(8): 839-845.
[9] Tehrani FR, Solaymani-Dodaran M, Tohidi M, et al. Modeling age at menopause using serum concentration of anti-mullerian hormone[J]. J Clin Endocrinol Metab, 2013, 98(2): 729-735.
[10] Sahmay S, Oncul M, Tuten A, et al. Anti-müllerian hormone levels as a predictor of the pregnancy rate in women of advanced reproductive age[J]. J Assist Reprod Genet, 2014, 31(11):1469-1474.
[11] Lukaszuk K, Liss J, Kunicki M, et al. Anti-Müllerian hormone(AMH)is a strong predictor of live birth in women undergoing assisted reproductive technology[J]. Reprod Biol, 2014, 14(3): 176-181.
[12] Tal R, Tal O, Seifer BJ, et al. Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: asystematic review and meta-analysis[J]. Fertil Steril, 2015, 103(1): 119-130.
[13] Li Y, Nie M, Liu Y, et al. The dynamic changes of anti-Mullerian hormone and inhibin B during controlled ovarian hyperstimulation in decreased ovarian reserve women and the effect on clinical outcome[J]. Gynecol Endocrinol, 2015, 31(6): 450-453.
[14] Tsakos E, Tolikas A, Daniilidis A, et al. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET[J]. Archives of Gynecology and Obstetrics, 2014, 290(6): 1249-1253.
[15] Vladimirov IK, Tacheva DM, Kalinov KB. Mean ovarian diameter(MOD)as a predictor of poor ovarian response[J]. J Assist Reprod Genet, 2004, 21(3): 73-77.
[16] Gingold JA, Lee JA, Rodriguez-Purata J, et al. Endometrial pattern, but not endometrial thickness, affects implantation rates in euploid embryo transfers[J]. Fertil Steril, 2015, 104(3): 620-628.
[17] Yuan X, Saravelos SH, Wang Q, et al. Endometrial thickness as a predictor of pregnancy outcomes in 10787 fresh IVF-ICSI cycles[J]. Reprod Biomed Online, 2016, 33(2): 197-205.
[18] Joo JK, Jeong JE, Kim CW, et al. Quantitative Assessment of Endometrial Volume and Uterine Vascularity and Pregnancy Outcome in Frozen-Thawed Embryo Transfer Cycles[J]. J Reprod Med,2016, 61(3-4): 133-138.
[19] 何玉洁, 王瑛, 土增荣, 等. 体外受精-胚胎移植过程中子宫收缩与妊娠结局相关性分析[J]. 中国药物与临床, 2015, 15(9): 1249-1252. HE Yujie, WANG Ying, TU Zengrong, et al. Collection between uterine contraction and pregnancy outcome in IVF/ICSI cycle[J]. Chinese Remedies & Clinics, 2015, 15(9): 1249-1252.
[20] Rabotti C, Sammali F, Kuijsters N, et al. Analysis of uterine activity in nonpregnant women by electrohysterography: a feasibility study[J]. Conf Proc IEEE Eng Med Biol Soc, 2015, 2015: 5916-5919. doi: 10.1109/EMBC.2015.7319738.
[21] Trolice MP. Live birth from a 46-year-old using fresh autologous oocytes through in vitro fertilization[J]. Fertil Steril, 2014, 102(1): 96-98.
[22] Yan G, Xie X, Wang Y, et al. Twin pregnancy after intracytoplasmic sperm injection in woman aged 49 using autologous oocytes by mild ovarian stimulation: a case report[J]. Int J Clin Exp Med, 2015, 8(11): 21707-21709.
[23] Demko ZP, Simon AL, McCoy RC, et al. Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism-based preimplantation genetic screening[J]. Fertil Steril, 2016, 105(5): 1307-1313.
[24] Gomes LM, Canha Ados S, Dzik A, et al. The age as a predictive factor in in vitro fertilization cycles[J]. Rev Bras Ginecol Obstet, 2009, 31(5): 230-234.
[25] Gleicher N, Kushnir VA, Albertini DF, et al. Improvements in IVF in women of advanced age[J]. J Endocrinol, 2016, 230(1): 1-6.
[26] Wennberg AL, Opdahl S, Bergh C, et al. Effect of maternal age on maternal and neonatal outcomes after assisted reproductive technology[J]. Fertil Steril, 2016, 106(5): 1142-1149.
[27] Davies MJ, Rumbold AR, Marino JL, et al. Maternal factors and the risk of birth defects after IVF and ICSI: a whole of population cohort study[J]. BJOG, 2016, doi: 10.1111/1471-0528.14365. [Epub ahead of print].
[28] Lee RK, Wu FS, Lin MH, et al. The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age[J]. Reprod Biol Endocrinol, 2011, 9: 115. doi: 10.1186/1477-7827-9-115.
[29] Goldman MB, Thornton KL, Ryley D, et al. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial(FORT-T)[J]. Fertil Steril, 2014, 101(6): 1574-1581.
[30] Li Y, Yang W, Chen X, et al. Comparison between follicular stimulation and luteal stimulation protocols with clomiphene and HMG in women with poor ovarian response[J]. Gynecol Endocrinol, 2016, 32(1): 74-77.
[31] Bassiouny YA, Dakhly DM, Bayoumi YA, et al. Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial[J]. Fertil Steril, 2016, 105(3): 697-702.
[32] 鹿群, 沈浣, 王丛, 等. 脱氢表雄酮对卵巢反应不良患者体外受精-胚胎移植的影响[J]. 山东大学学报(医学版), 2013, 5(12): 84-92. LU Qun, SHEN Huan, WANG Cong, et al. Dehydroepiandrosterone supplementation improve in vitro fertilization outcome among women with poor response[J]. Journal of Shandong University(Health Sciences), 2013, 5(12): 84-92.
[33] Gat I, Blanco Mejia S, Balakier H, et al. The use of coenzyme Q10 and DHEA during IUI and IVF cycles in patients with decreased ovarian reserve[J]. Gynecol Endocrinol, 2016, 32(7): 534-537.
[34] Fernando S, Rombauts L. Melatonin: shedding light on infertility? ——A review of the recent literature[J]. J Ovarian Res, 2014, 7: 98. Published online 2014 Oct 21. doi: 10.1186/s13048-014-0098-y.
[35] Zhou L, Xia Y, Ma X, et al. Effects of “enstrual cycle-based acupuncture therapy” on IVF-ET in patients with decline in ovarian reserve[J]. Zhong Guo Zhen Jiu, 2016, 36(1): 25-28.
[36] Younis JS, Izhaki I, Ben-Ami M, et al. The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: a prospective randomized controlled study[J]. Clin Endocrinol(Oxf), 2016, 84(1): 99-106.
[37] Schwarze JE, Crosby JA, Zegers-Hochschild F. Addition of neither recombinant nor urinary luteinizing hormone was associated with an improvement in the outcome of autologous in vitro fertilization/intracytoplasmatic sperm injection cycles under regular clinical settings: a multicenter observational analysis[J]. Fertil Steril, 2016, 106(7):1714-1717.e1.
[38] Bastu E, Buyru F, Ozsurmeli M, et al. A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 203: 30-34. doi: 10.1016/j.ejogrb.2016.05.027.
[39] Yasa C, Bastu E, Dural O, et al. Evaluation of low-dose letrozole addition to ovulation induction in IVF.Evaluation of low-dose letrozole addition to ovulation induction in IVF[J]. Clin Exp Obstet Gynecol, 2013, 40(1): 98-100.
[40] Suzuki N, Yoshioka N, Takae S. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency[J]. Hum Reprod, 2015, 30(3): 608-615.
[41] Paulson RJ, Fauser BC, Vuong LT, et al. Can we modify assisted reproductive technology practice to broaden reproductive care access?[J]. Fertil Steril, 2016, 105(5): 1138-1143.
[42] Fang C, Tang J, Huang R, et al. Comparison of IVF outcomes using conventional insemination and ICSI in ovarian cycles in which only one or two oocytes are obtained[J]. J Gynecol Obstet Biol Reprod(Paris), 2012, 41(7): 650-656.
[43] Tannus S, Son WY, Gilman A, et al. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age[J]. Hum Reprod, 2016, doi:10.1093/humrep/dew298.
[44] Lee HL, McCxulloh DH, Hodes-Wertz B, et al. In vitro fertilization with preimplantation genetic screening improves implantation and live birth in women age 40 through 43[J]. J Assist Reprod Genet, 2015, 32(3): 435-444.
[45] Lathi RB, Kort JD. Caution: counseling patients with diminished ovarian reserve and recurrent pregnancy loss about in vitro fertilization with preimplantation genetic screening[J]. Fertil Steril, 2016, 106(5): 1041-1042.
[46] 罗燕群, 刘风华, 易艳红, 等. 年龄、移植胚胎数量、质量与临床妊娠率的关系[J]. 生殖医学杂志, 2014, 23(5): 361-366. LUO Yanqun, LIU Fenghua, YI Yanhong, et al. Effect of number and quality of embryo transferred on clinical pregnancy rate in women of different age[J]. J Reprod Med, 2014, 23(5): 361-366.
[47] Toner JP, Grainger DA, Frazier LM. Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience, 1996-1998[J]. Fertil Steril, 2002, 78(5): 1038-1045.
[48] Ethics Committee of the American Society for Reproductive Medicine. Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion[J]. Fertil Steril, 2016, 106(5): 3-7.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed